Senti Biosciences Holdings, Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2022 | $-10.1M | $-17.4M | $7.4M | $661.0K |
| Jun 2022 | $-5.7M | $-17.0M | $11.3M | $9.2M |
| Sep 2022 | $-10.1M | $-24.3M | $14.2M | $2.3M |
| Dec 2022 | $-9.0M | $-17.5M | $8.5M | $4.2M |
| Mar 2023 | $-16.3M | $-22.8M | $6.5M | $3.8M |
| Jun 2023 | $-13.7M | $-17.3M | $3.7M | $3.4M |
| Sep 2023 | $-15.4M | $-17.2M | $1.9M | $409.0K |
| Dec 2023 | $-7.0M | $-7.0M | $4.0K | $2.1M |
| Mar 2024 | $-11.7M | $-11.7M | $15.0K | $1.3M |
| Jun 2024 | $-8.3M | $-8.3M | $0 | $-776.0K |
| Sep 2024 | $-7.9M | $-7.9M | $0 | $668.0K |
| Dec 2024 | $-13.5M | $-13.5M | $11.0K | $605.0K |
| Mar 2025 | $-14.1M | $-14.1M | $0 | $1.2M |
| Jun 2025 | $-13.1M | $-13.3M | $196.0K | $1.5M |
| Sep 2025 | $-9.4M | $-9.4M | $0 | $1.6M |
| Dec 2025 | $-6.9M | $-6.9M | $0 | $1.4M |
| Mar 2026 | $-7.5M | $-7.5M | — | $1.3M |
| Jun 2026 | $-14.2M | $-14.2M | — | $1.0M |